降圧薬の再利用で遺伝性失明疾患の視力喪失を防ぐ可能性(Repurposing a blood pressure drug may prevent vision loss in inherited blinding diseases)

ad

2025-04-15 アメリカ国立衛生研究所(NIH)

米国NIHの研究で、高血圧治療薬レセルピンが遺伝性網膜疾患・網膜色素変性症(RP)の視力喪失を防ぐ可能性が示されました。動物実験により、レセルピンは視細胞の構造と機能を維持し、光受容伝達を保護。また、雌ラットにより強い保護効果を示し、性差が発見されました。RPは多数の遺伝子変異で起こりますが、本薬は遺伝子非依存的な治療法として期待されており、今後は誘導体開発も進められています。

<関連情報>

常染色体優性網膜色素変性症のロドプシンP23Hモデルラットにおけるレセルピンによる光受容体変性の性特異的減衰 Sex-specific attenuation of photoreceptor degeneration by reserpine in a rhodopsin P23H rat model of autosomal dominant retinitis pigmentosa

Hyun Beom Song,Laura Campello,Anupam K Mondal,Holly Y Chen,Milton A English,Michael Glen,Phillip Vanlandingham,Rafal Farjo,Anand Swaroop
eLife  Reviewed Preprint v2:March 27, 2025
DOI:https://doi.org/10.7554/eLife.103888.2

降圧薬の再利用で遺伝性失明疾患の視力喪失を防ぐ可能性(Repurposing a blood pressure drug may prevent vision loss in inherited blinding diseases)

Abstract

Inherited retinal degenerations (IRDs) constitute a group of clinically and genetically diverse vision-impairing disorders. Retinitis pigmentosa (RP), the most common form of IRD, is characterized by gradual dysfunction and degeneration of rod photoreceptors, followed by the loss of cone photoreceptors. Recently, we identified reserpine as a lead molecule for maintaining rod survival in mouse and human retinal organoids as well as in the rd16 mouse, which phenocopy Leber congenital amaurosis caused by mutations in the cilia-centrosomal gene CEP290 (Chen et al., 2023). Here, we show the therapeutic potential of reserpine in a rhodopsin P23H rat model of autosomal dominant RP. At postnatal day (P) 68, when males and females are analyzed together, the reserpine-treated rats exhibit higher rod-derived scotopic b-wave amplitudes compared to the controls with little or no change in scotopic a-wave or cone-derived photopic b-wave. Interestingly, the reserpine-treated female rats display enhanced scotopic a- and b-waves and photopic b-wave responses at P68, along with a better contrast threshold and increased outer nuclear layer thickness. The female rats demonstrate better preservation of both rod and cone photoreceptors following reserpine treatment. Retinal transcriptome analysis reveals sex-specific responses to reserpine, with significant upregulation of phototransduction genes and proteostasis-related pathways, and notably, genes associated with stress response. This study builds upon our previously reported results reaffirming the potential of reserpine for gene-agnostic treatment of IRDs and emphasizes the importance of biological sex in retinal disease research and therapy development.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました